Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Breast Cancer

  Free Subscription


16.03.2020

3 Am J Surg
1 Ann Oncol
1 Ann Surg
2 Ann Surg Oncol
1 BMC Cancer
5 Breast Cancer
2 Breast Cancer Res
1 Breast Cancer Res Treat
2 Breast J
3 Cancer
2 Clin Breast Cancer
1 Eur J Cancer
1 Eur Radiol
1 Exp Cell Res
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Surg Oncol
2 JAMA
1 Lancet
1 Lancet Oncol
10 PLoS One
2 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. LIU C, Cheifetz R, Brown C, Nichol A, et al
    Do surgeons convey all the details? A provincial assessment of operative reporting for breast cancer.
    Am J Surg. 2020 Feb 29. pii: S0002-9610(20)30134.
    PubMed     Text format     Abstract available

  2. FENG Y, He XG, Zhou CM, Zhang QY, et al
    Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study.
    Am J Surg. 2020 Feb 28. pii: S0002-9610(20)30125.
    PubMed     Text format     Abstract available

  3. HANGGE PT, Jogerst K, Mohsen A, Kosiorek H, et al
    Making an informed choice: Which breast reconstruction type has the lowest complication rate?
    Am J Surg. 2019;218:1040-1045.
    PubMed     Text format     Abstract available


    Ann Oncol

  4. BRANDAO M, Coens C, Ignatiadis M
    Patient-reported outcomes and genomic signatures: tools to tailor adjuvant endocrine treatment?
    Ann Oncol. 2019;30:1677-1681.
    PubMed     Text format    


    Ann Surg

  5. KONTOS M, Moris D, Constantinidou A
    Comment on "Surgical Delay in Nipple-sparing Mastectomy".
    Ann Surg. 2019;270:e99.
    PubMed     Text format    


    Ann Surg Oncol

  6. COHEN BL, Macedo FI
    ASO Author Reflections: SLNB with RT May Be Sufficient in Occult Breast Cancer after NAC.
    Ann Surg Oncol. 2020 Mar 10. pii: 10.1245/s10434-020-08345.
    PubMed     Text format    

  7. MUDGWAY R, Chavez de Paz Villanueva C, Lin AC, Senthil M, et al
    The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy.
    Ann Surg Oncol. 2020 Mar 10. pii: 10.1245/s10434-020-08310.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. MEALEY NE, O'Sullivan DE, Pader J, Ruan Y, et al
    Mutational landscape differences between young-onset and older-onset breast cancer patients.
    BMC Cancer. 2020;20:212.
    PubMed     Text format     Abstract available


    Breast Cancer

  9. TSUDA H
    Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition).
    Breast Cancer. 2020 Mar 9. pii: 10.1007/s12282-020-01074.
    PubMed     Text format     Abstract available

  10. KHALIS M, Dossus L, Rinaldi S, Biessy C, et al
    Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case-control study.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01072.
    PubMed     Text format     Abstract available

  11. WANG X, Zhou X, Zeng F, Wu X, et al
    miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01075.
    PubMed     Text format     Abstract available

  12. MATSUNUMA R, Watanabe T, Hozumi Y, Koizumi K, et al
    Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01077.
    PubMed     Text format     Abstract available

  13. ZEHRA S, Doyle F, Barry M, Walsh S, et al
    Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis.
    Breast Cancer. 2020 Mar 12. pii: 10.1007/s12282-020-01076.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  14. ETTL J, Im SA, Ro J, Masuda N, et al
    Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
    Breast Cancer Res. 2020;22:27.
    PubMed     Text format     Abstract available

  15. ZUNDELEVICH A, Dadiani M, Kahana-Edwin S, Itay A, et al
    Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
    Breast Cancer Res. 2020;22:28.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  16. O'SULLIVAN CC, Irshad S, Wang Z, Tang Z, et al
    Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period.
    Breast Cancer Res Treat. 2020 Mar 11. pii: 10.1007/s10549-020-05585.
    PubMed     Text format     Abstract available


    Breast J

  17. VAN EGDOM LSE, Pusic A, Verhoef C, Hazelzet JA, et al
    Machine learning with PROs in breast cancer surgery; caution: Collecting PROs at baseline is crucial.
    Breast J. 2020 Mar 11. doi: 10.1111/tbj.13804.
    PubMed     Text format     Abstract available

  18. HOLLINGSWORTH AB, Pearce MR, Stough RG
    Breast cancer survival following MRI detection in a high-risk screening program.
    Breast J. 2020 Mar 12. doi: 10.1111/tbj.13813.
    PubMed     Text format     Abstract available


    Cancer

  19. HERCULES SM, Hercules JC, Ansari A, Date SAJ, et al
    High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32771.
    PubMed     Text format     Abstract available

  20. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32815.
    PubMed     Text format     Abstract available

  21. CHEN L, Alexanderson KAE
    Trajectories of sickness absence and disability pension in the 2 years before and 3 years after breast cancer diagnosis: A Swedish longitudinal population-based cohort study.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32820.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  22. ALBESHAN SM, Hossain SZ, Mackey MG, Brennan PC, et al
    Can Breast Self-examination and Clinical Breast Examination Along With Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations With Advanced Stages at Diagnosis?
    Clin Breast Cancer. 2020 Feb 11. pii: S1526-8209(20)30031.
    PubMed     Text format     Abstract available

  23. YOO TK, Kim SJ, Lee J, Lee SB, et al
    A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Clin Breast Cancer. 2019 Dec 6. pii: S1526-8209(19)30760.
    PubMed     Text format     Abstract available


    Eur J Cancer

  24. ZAMANI P, Teymouri M, Nikpoor AR, Navashenaq JG, et al
    Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer.
    Eur J Cancer. 2020;129:80-96.
    PubMed     Text format     Abstract available


    Eur Radiol

  25. QI Y, Cui X, Han M, Li R, et al
    Radiomics analysis of lung CT image for the early detection of metastases in patients with breast cancer: preliminary findings from a retrospective cohort study.
    Eur Radiol. 2020 Mar 12. pii: 10.1007/s00330-020-06745.
    PubMed     Text format     Abstract available


    Exp Cell Res

  26. GUNNARSDOTTIR FB, Hagerling C, Bergenfelz C, Mehmeti M, et al
    Inflammatory macrophage derived TNFalpha downregulates estrogen receptor alpha via FOXO3a inactivation in human breast cancer cells.
    Exp Cell Res. 2020 Mar 4:111932. doi: 10.1016/j.yexcr.2020.111932.
    PubMed     Text format     Abstract available


    Int J Cancer

  27. ARMAROLI P, Riggi E, Basu P, Anttila A, et al
    Performance Indicators in Breast Cancer Screening in the European Union: A Comparison Across Countries of Screen Positivity and Detection Rates.
    Int J Cancer. 2020 Mar 11. doi: 10.1002/ijc.32968.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  28. SUN GY, Wang SL, Song YW, Jin J, et al
    Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients with Breast Cancer: A Post-Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Mar 5. pii: S0360-3016(20)30883.
    PubMed     Text format     Abstract available


    J Clin Oncol

  29. LIGIBEL JA
    Could the Women's Health Initiative Breathe New Life Into Breast Cancer Prevention?
    J Clin Oncol. 2020 Mar 9:JCO2000148. doi: 10.1200/JCO.20.00148.
    PubMed     Text format    


    J Surg Oncol

  30. WECSLER J, Jeong YJ, Raghavendra AS, Mack WJ, et al
    Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers.
    J Surg Oncol. 2020;121:589-598.
    PubMed     Text format     Abstract available


    JAMA

  31. KURIAN AW, Bernhisel R, Larson K, Caswell-Jin JL, et al
    Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer.
    JAMA. 2020;323:995-997.
    PubMed     Text format    

  32. QUAGLIARELLO V
    Tiny Branches.
    JAMA. 2020;323:711-712.
    PubMed     Text format    


    Lancet

  33. SPRING LM, Wander SA, Andre F, Moy B, et al
    Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.
    Lancet. 2020;395:817-827.
    PubMed     Text format     Abstract available


    Lancet Oncol

  34. STIRRUPS R
    Pembrolizumab for triple-negative breast cancer.
    Lancet Oncol. 2020 Mar 5. pii: S1470-2045(20)30154.
    PubMed     Text format    


    PLoS One

  35. WU WP, Wu HK, Chen CJ, Lee CW, et al
    Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
    PLoS One. 2019;14:e0222917.
    PubMed     Text format     Abstract available

  36. HECK L, Dierolf M, Jud C, Eggl E, et al
    Contrast-enhanced spectral mammography with a compact synchrotron source.
    PLoS One. 2019;14:e0222816.
    PubMed     Text format     Abstract available

  37. SHETH M, Gerovitch A, Welsch R, Markuzon N, et al
    The Univariate Flagging Algorithm (UFA): An interpretable approach for predictive modeling.
    PLoS One. 2019;14:e0223161.
    PubMed     Text format     Abstract available

  38. LEE SJ, Sim TS, Shin HY, Lee J, et al
    Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.
    PLoS One. 2019;14:e0223193.
    PubMed     Text format     Abstract available

  39. HE TF, Yost SE, Frankel PH, Dagis A, et al
    Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis.
    PLoS One. 2020;15:e0229955.
    PubMed     Text format     Abstract available

  40. MIAO LF, Ye XH, He XF
    Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    PLoS One. 2020;15:e0216147.
    PubMed     Text format     Abstract available

  41. VILLARREAL-GARZA C, Lopez-Martinez EA, Deneken-Hernandez Z, Maffuz-Aziz A, et al
    Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients.
    PLoS One. 2020;15:e0228884.
    PubMed     Text format     Abstract available

  42. KUSI G, Boamah Mensah AB, Boamah Mensah K, Dzomeku VM, et al
    Caregiving motivations and experiences among family caregivers of patients living with advanced breast cancer in Ghana.
    PLoS One. 2020;15:e0229683.
    PubMed     Text format     Abstract available

  43. AN YY, Kim SH, Kang BJ, Suh YJ, et al
    Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer.
    PLoS One. 2020;15:e0230347.
    PubMed     Text format     Abstract available

  44. RATH M, Li Q, Li H, Lindstrom S, et al
    Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
    PLoS One. 2020;15:e0230529.
    PubMed     Text format     Abstract available


    Radiother Oncol

  45. FASTNER G, Reitsamer R, Urbanski B, Kopp P, et al
    Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
    Radiother Oncol. 2020;146:136-142.
    PubMed     Text format     Abstract available

  46. BOEKEL NB, Boekel LY, Buddeke J, Jacobse JN, et al
    Prognosis of acute coronary syndromes after radiotherapy for breast cancer.
    Radiother Oncol. 2020;146:110-117.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: